U.S. flag

An official website of the United States government

NM_000371.4(TTR):c.148G>T (p.Val50Leu) AND Amyloidosis, hereditary systemic 1

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jan 31, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003050501.3

Allele description [Variation Report for NM_000371.4(TTR):c.148G>T (p.Val50Leu)]

NM_000371.4(TTR):c.148G>T (p.Val50Leu)

Gene:
TTR:transthyretin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
18q12.1
Genomic location:
Preferred name:
NM_000371.4(TTR):c.148G>T (p.Val50Leu)
HGVS:
  • NC_000018.10:g.31592974G>T
  • NG_009490.1:g.6208G>T
  • NM_000371.4:c.148G>TMANE SELECT
  • NP_000362.1:p.Val50Leu
  • NP_000362.1:p.Val50Leu
  • LRG_416t1:c.148G>T
  • LRG_416:g.6208G>T
  • LRG_416p1:p.Val50Leu
  • NC_000018.9:g.29172937G>T
  • NM_000371.3:c.148G>T
Protein change:
V50L
Molecular consequence:
  • NM_000371.4:c.148G>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Amyloidosis, hereditary systemic 1 (AMYLD1)
Synonyms:
Amyloidosis Transthyretin related; Amyloid polyneuropathy transthyretin related; Transthyretin amyloidosis; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0971004; MedGen: C2751492; Orphanet: 85447; Orphanet: 85451; OMIM: 105210

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003442588Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Jan 31, 2024)
germlineclinical testing

PubMed (7)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

A novel transthyretin mutation at position 30 (Leu for Val) associated with familial amyloidotic polyneuropathy.

Murakami T, Atsumi T, Maeda S, Tanase S, Ishikawa K, Mita S, Kumamoto T, Araki S, Ando M.

Biochem Biophys Res Commun. 1992 Aug 31;187(1):397-403.

PubMed [citation]
PMID:
1520326

Report of five rare or previously unknown amyloidogenic transthyretin mutations disclosed in Sweden.

Suhr OB, Andersen O, Aronsson T, Jonasson J, Kalimo H, Lundahl C, Lundgren HE, Melberg A, Nyberg J, Olsson M, Sandberg A, Westermark P.

Amyloid. 2009 Dec;16(4):208-14. doi: 10.3109/13506120903421587.

PubMed [citation]
PMID:
19922332
See all PubMed Citations (7)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV003442588.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (7)

Description

This sequence change replaces valine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 50 of the TTR protein (p.Val50Leu). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of familial transthyretin amyloidosis (PMID: 1520326, 19922332, 27212199). This variant is also known as p.Val30Leu. ClinVar contains an entry for this variant (Variation ID: 2138144). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TTR protein function with a positive predictive value of 95%. This variant disrupts the p.Val50 amino acid residue in TTR. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 22620962, 23833285, 24555660). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024